Dec. 8, 2005 — The US Food and Drug Administration (FDA) has warned healthcare professionals that exposure to paroxetine during the first trimester of pregnancy may increase the risk for congenital ...

May 12, 2006 — The US Food and Drug Administration (FDA) and GlaxoSmithKline have warned healthcare professionals regarding the potential increased risk for suicidal behavior associated with use of ...

PITTSBURGH, Oct. 23 -- Mylan Inc. today announced that it and its subsidiary Mylan Pharmaceuticals Inc. have entered into a patent license and settlement agreement with GlaxoSmithKline (GSK) relating ...

Mylan Granted Temporary Restraining Order Against GlaxoSmithKline and Apotex Prohibiting the Supply, Sale and/or Importing of a Generic Version of Paxil CR PITTSBURGH, Sept 21, 2010 /PRNewswire via ...

Mylan Inc., the generic-drug maker with an exclusive agreement to sell a copy of GlaxoSmithKline Plc’s Paxil CR, said it won a temporary court order blocking Apotex Inc. from also selling the mood ...

ATLANTA–Emory University researchers have found that paroxetine HCL (Paxil) produces measurable improvement in verbal memory and also increases the size of the hippocampus, a key area of the brain ...

Paroxetine (as HCl) 10mg/5mL; orange-flavored liq. Increased risk of suicidal thoughts and behavior in children and young adults; monitor all patients for clinical worsening or unusual changes.

Paroxetine is prescribed to treat certain mental health conditions, such as major depressive disorder (commonly known as depression), obsessive-compulsive disorder (OCD), and social anxiety disorder.

SAN FRANCISCO (MarketWatch) -- Teva Pharmaceutical Industries Ltd. said Tuesday that the Food and Drug Administration has granted final approval for its paroxetine hydrochloride tablets, the generic ...

The order was entered today, and the court has scheduled further hearings on the matter for Oct. 18. Mylan is currently selling all three strengths of Paroxetine HCl ER. Mylan Inc. ranks among the ...